The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, longstanding disease

Atopic Dermatitis

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

JAMA Dermatol.

Simpson EL, Guttman-Yassky E, Margolis DJ, Feldman SR, Qureshi A, Hata T, Mastey V, Wei W, Eckert L, Chao J, Arnold RJG, Yu T, Vekeman F, Suárez-Fariñas M, Gadkari A

doi: 10.1001/jamadermatol.2018.

Atopic Dermatitis

Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review

JAMA Dermatol.

Lam M, Zhu JW, Maqbool T, Adam G, Tadrous M, Rochon P, Drucker AM

doi: 10.1001/jamadermatol.2020.2940.

Atopic Dermatitis

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

J Am Acad Dermatol.

Thyssen JP, Toft PB, Halling-Overgaard AS, Gislason GH, Skov L, Egeberg A

doi: 10.1016/j.jaad.2017.03.003.

Atopic Dermatitis

Increasing Severity of Early-Onset Atopic Dermatitis, But Not Late-Onset, Associates with Development of Aeroallergen Sensitization and Allergic Rhinitis in Childhood

Allergy

Schoos AM, Chawes BL, Bønnelykke K, Stokholm J, Rasmussen MA, Bisgaard H

doi: 10.1111/all.15108

Atopic Dermatitis

Atopic dermatitis endotypes based on allergen sensitization, reactivity to Staphylococcus aureus antigens, and underlying systemic inflammation

J Allergy Clin Immunol Pract.

Leonard A, Wang J, Yu L, Liu H, Estrada Y, Greenlees L, McPhee R, Ruzin A, Guttman-Yassky E, Howell MD

doi: 10.1016/j.jaip.2019.08.013.

Atopic Dermatitis

Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood

JAMA Pediatr.

Roduit C, Frei R, Depner M, Karvonen AM, Renz H, Braun-Fahrländer C, Schmausser-Hechfellner E, Pekkanen J, Riedler J, Dalphin JC, von Mutius E, Lauener RP; and the PASTURE study group, Hyvärinen A, Kirjavainen P, Remes S, Roponen M, Dalphin ML, Kaulek V, Ege M, Genuneit J, Illi S, Kabesch M, Schaub B, Pfefferle PI, Doekes G

doi: 10.1001/

Juvenile Idiopathic Arthritis

Catastrophic adult-onset Still's disease as a distinct life-threatening clinical subset: case-control study with dimension reduction analysis

Arthritis Res Ther

Wahbi A, Tessoulin B, Bretonnière C, Boileau J, Carpentier D, Decaux O, Fardet L, Geri G, Godmer P, Goujard C, Maisonneuve H, Mari A, Pouchot J, Ziza JM, Georgin-Lavialle S, Hamidou M, Néel A

doi: 10.1186/s13075-021-02631-7

COMMENTED

Atopic Dermatitis

The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study

Br J Dermatol.

Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Guttman-Yassky E

doi: 10.1111/bjd.17932.

Atopic DermatitisPsoriasis

Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults

Br J Dermatol.

Egeberg A, Griffiths CEM, Williams HC, Andersen YMF, Thyssen JP

doi: 10.1111/bjd.18622.

Related content

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

Increasing Severity of Early-Onset Atopic Dermatitis, But Not Late-Onset, Associates with Development of Aeroallergen Sensitization and Allergic Rhinitis in Childhood

Atopic dermatitis endotypes based on allergen sensitization, reactivity to Staphylococcus aureus antigens, and underlying systemic inflammation

Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood

Catastrophic adult-onset Still's disease as a distinct life-threatening clinical subset: case-control study with dimension reduction analysis

The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study

Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults